Co Approvel Tablet
Co-Approvel Tablet Contains Irbesartan 150mg + HCTZ 12.5mg which is a combination medication for high blood pressure that also reduces fluid retention.
Co-Approvel Tablet Contains Irbesartan 150mg + HCTZ 12.5mg which is a combination medication for high blood pressure that also reduces fluid retention.